Coronavirus Disease 2019 and Pituitary Apoplexy : A Single-Center Case Series and Review of the Literature
Copyright © 2021 Elsevier Inc. All rights reserved..
BACKGROUND: Pituitary apoplexy (PA) is a rare, but life-threatening, condition characterized by pituitary infarction and hemorrhage, most often in the setting of a preexisting adenoma. The risk factors and mechanisms associated with PA are poorly understood. Although neurovascular manifestations of coronavirus disease 2019 (COVID-19) infection have been documented, its association with PA has not yet been determined.
METHODS: From a prospectively collected database of patients treated at a tertiary care center for pituitary adenoma, we conducted a retrospective medical record review of PA cases during the COVID-19 pandemic from March 2020 to December 2020. We also conducted a literature review to identify other reported cases.
RESULTS: We identified 3 consecutive cases of PA and concomitant COVID-19 infection. The most common symptoms at presentation were headache and vision changes. The included patients were successfully treated with surgical decompression and medical management of the associated endocrinopathy, ultimately experiencing improvement in their visual symptoms at the latest follow-up examination. COVID-19 infection in the perioperative period was corroborated by polymerase chain reaction test results in all the patients.
CONCLUSIONS: With the addition of our series to the literature, 10 cases of PA in the setting of COVID-19 infection have been confirmed. The present series was limited in its ability to draw conclusions about the relationship between these 2 entities. However, COVID-19 infection might represent a risk factor for the development of PA. Further studies are required.
| Errataetall: |
CommentIn: World Neurosurg. 2022 Jan;157:252-253. - PMID 34929775 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:152 |
|---|---|
| Enthalten in: |
World neurosurgery - 152(2021) vom: 20. Aug., Seite e678-e687 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Martinez-Perez, Rafael [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 16.09.2021 Date Revised 21.12.2022 published: Print-Electronic CommentIn: World Neurosurg. 2022 Jan;157:252-253. - PMID 34929775 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.wneu.2021.06.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326776354 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326776354 | ||
| 003 | DE-627 | ||
| 005 | 20231225195327.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.wneu.2021.06.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1089.xml |
| 035 | |a (DE-627)NLM326776354 | ||
| 035 | |a (NLM)34129968 | ||
| 035 | |a (PII)S1878-8750(21)00829-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martinez-Perez, Rafael |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coronavirus Disease 2019 and Pituitary Apoplexy |b A Single-Center Case Series and Review of the Literature |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.09.2021 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: World Neurosurg. 2022 Jan;157:252-253. - PMID 34929775 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Pituitary apoplexy (PA) is a rare, but life-threatening, condition characterized by pituitary infarction and hemorrhage, most often in the setting of a preexisting adenoma. The risk factors and mechanisms associated with PA are poorly understood. Although neurovascular manifestations of coronavirus disease 2019 (COVID-19) infection have been documented, its association with PA has not yet been determined | ||
| 520 | |a METHODS: From a prospectively collected database of patients treated at a tertiary care center for pituitary adenoma, we conducted a retrospective medical record review of PA cases during the COVID-19 pandemic from March 2020 to December 2020. We also conducted a literature review to identify other reported cases | ||
| 520 | |a RESULTS: We identified 3 consecutive cases of PA and concomitant COVID-19 infection. The most common symptoms at presentation were headache and vision changes. The included patients were successfully treated with surgical decompression and medical management of the associated endocrinopathy, ultimately experiencing improvement in their visual symptoms at the latest follow-up examination. COVID-19 infection in the perioperative period was corroborated by polymerase chain reaction test results in all the patients | ||
| 520 | |a CONCLUSIONS: With the addition of our series to the literature, 10 cases of PA in the setting of COVID-19 infection have been confirmed. The present series was limited in its ability to draw conclusions about the relationship between these 2 entities. However, COVID-19 infection might represent a risk factor for the development of PA. Further studies are required | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Neurosurgery | |
| 650 | 4 | |a Pituitary adenoma | |
| 650 | 4 | |a Pituitary apoplexy | |
| 700 | 1 | |a Kortz, Michael W |e verfasserin |4 aut | |
| 700 | 1 | |a Carroll, Benjamin W |e verfasserin |4 aut | |
| 700 | 1 | |a Duran, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Neill, James S |e verfasserin |4 aut | |
| 700 | 1 | |a Luzardo, Gustavo D |e verfasserin |4 aut | |
| 700 | 1 | |a Zachariah, Marcus A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World neurosurgery |d 2010 |g 152(2021) vom: 20. Aug., Seite e678-e687 |w (DE-627)NLM197924441 |x 1878-8769 |7 nnns |
| 773 | 1 | 8 | |g volume:152 |g year:2021 |g day:20 |g month:08 |g pages:e678-e687 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.wneu.2021.06.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 152 |j 2021 |b 20 |c 08 |h e678-e687 | ||